Diffuse Bio

Curated by Signal

Provider of AI-based drug candidate identification solutions for drug discovery

Overview

Provider of AI-based drug candidate identification solutions for drug discovery. It is offering AI-software platform for drug design and experimental validation of AI-generated proteins and diffusion models for protein structure and sequences.

Key facts

Founded: 2022
Headquarters: San Francisco, United States
Stage: Sign up to view
Industry: Health Technology

Business model

2 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

MDToolbox
e-RX, EPCS & HIE integration solutions
Health TechnologyRichland, United States
PeopleOne Health
Provider of employee health management solutions
Health TechnologyAltoona, United States
NEMT
Provider of non-emergency medical transportation software
Health TechnologyClarkston, United States

About Diffuse Bio

What does Diffuse Bio do?

Provider of AI-based drug candidate identification solutions for drug discovery.

Where is Diffuse Bio headquartered?

Diffuse Bio is headquartered in San Francisco, United States.

When was Diffuse Bio founded?

Diffuse Bio was founded in 2022.

Which sector is Diffuse Bio in?

Diffuse Bio operates in Health Technology.

Who are Diffuse Bio's competitors?

Companies similar to Diffuse Bio include MDToolbox, PeopleOne Health, and NEMT.